Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
CONCLUSION: Gastrectomy combined with cytoreductive surgery and HIPEC was feasible using 460 mg/m2 oxaliplatin and 50 mg/m2 normothermic docetaxel.
PMID: 32277764 [PubMed - as supplied by publisher]
Source: The British Journal of Surgery - Category: Surgery Authors: van der Kaaij RT, Wassenaar ECE, Koemans WJ, Sikorska K, Grootscholten C, Los M, Huitema A, Schellens JHM, Veenhof AAFA, Hartemink KJ, Aalbers AGJ, van Ramshorst B, Boerma D, Boot H, van Sandick JW Tags: Br J Surg Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Cytology | Docetaxel | Eloxatin | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Peritoneal Cancer | Study | Surgery | Taxotere | Toxicology | UK Health